干细胞治疗糖尿病病的有效性:系统性审查和元分析
Hongyu Du1, Chen Xie1, Yiqin Yuan1
1School of Rehabilitation Medicine, Gannan Medical University, Ganzhou, Jiangxi, China.
Frontiers in medicine
|September 17, 2025
概括
干细胞疗法 (SCT) 对糖尿病病 (DKD) 是有前途的,改善了像eGFR和SCr.这样的功能标志物. 然而,它没有显著影响血糖或UACR,并注意到不良事件.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 再生医学是一种再生医学.
- 糖尿病学 糖尿病学
背景情况:
- 糖尿病病 (DKD) 是糖尿病的一个主要并发症.
- 动物研究表明干细胞疗法 (SCT) 对DKD的疗效.
- 在DKD患者中SCT的临床证据仍然有限.
研究的目的:
- 系统地审查和分析SCT在DKD患者的疗效.
- 评估SCT对关键功能和血糖指标的影响.
- 评估SCT在DKD患者中的安全性.
主要方法:
- 在主要数据库 (PubMed,EMBASE,Cochrane,Web of Science) 进行全面的文献搜索,截至2024年3月.
- 包括四项研究,共90名参与者 (53名接受SCT).
- 使用RevMan V.5.4软件进行的统计分析.
主要成果:
- SCT显著改善了估计的淋巴细胞过率 (eGFR) 和降低了血清肌素 (SCr).
- 微专尿 (MAU) 水平在SCT后降低,但尿中的专素与肌素比率 (UACR) 没有显著改善.
- 血糖水平没有受到SCT的显著影响,并且不良事件,特别是尿道和神经系统事件,在SCT组中更频繁.
结论:
- 干细胞治疗显示出改善功能 (eGFR,SCr) 和减少DKD患者的微专尿的潜力.
- 在这种患者群体中,SCT似乎没有改善血糖控制或UACR.
- 需要进一步的研究来优化SCT协议,并管理DKD治疗中相关的不良事件.
更多相关视频
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
616
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
9.5K
相关概念视频
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Kidney Transplant I: Introduction
345
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
345
Chronic Kidney Disease III: Interprofessional Care
344
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
344
